The EXCEL Trial: The Interventionalists’ Perspective
Left main stem (LMS) disease is identified in up to 5% of diagnostic angiography cases, and is associated with significant morbidity and mortality due to the proportion of myocardium it subtends. In the past 10 years, there has been a significant change in the way we contemplate treating lesions in...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a1a821c0da314a6389592702409044bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a1a821c0da314a6389592702409044bd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a1a821c0da314a6389592702409044bd2021-12-04T16:03:56ZThe EXCEL Trial: The Interventionalists’ Perspective10.15420/ecr.2020.321758-37641758-3756https://doaj.org/article/a1a821c0da314a6389592702409044bd2021-03-01T00:00:00Zhttps://www.ecrjournal.com/articleindex/ecr.2020.32https://doaj.org/toc/1758-3756https://doaj.org/toc/1758-3764Left main stem (LMS) disease is identified in up to 5% of diagnostic angiography cases, and is associated with significant morbidity and mortality due to the proportion of myocardium it subtends. In the past 10 years, there has been a significant change in the way we contemplate treating lesions in the LMS due to evolving experience and evidence in percutaneous coronary intervention (PCI) strategies and technologies. This has been reflected in recent changes in European and International guidance on managing patients with this lesion subset. Here, the authors provide an overview of the current literature regarding the management of LMS disease using PCI in light of new developments and emerging concepts in this field, specifically looking at the recent EXCEL trial.George William HunterVinoda SharmaChetan VarmaDerek ConnollyRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENEuropean Cardiology Review , Vol 16, Iss , Pp - (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 George William Hunter Vinoda Sharma Chetan Varma Derek Connolly The EXCEL Trial: The Interventionalists’ Perspective |
description |
Left main stem (LMS) disease is identified in up to 5% of diagnostic angiography cases, and is associated with significant morbidity and mortality due to the proportion of myocardium it subtends. In the past 10 years, there has been a significant change in the way we contemplate treating lesions in the LMS due to evolving experience and evidence in percutaneous coronary intervention (PCI) strategies and technologies. This has been reflected in recent changes in European and International guidance on managing patients with this lesion subset. Here, the authors provide an overview of the current literature regarding the management of LMS disease using PCI in light of new developments and emerging concepts in this field, specifically looking at the recent EXCEL trial. |
format |
article |
author |
George William Hunter Vinoda Sharma Chetan Varma Derek Connolly |
author_facet |
George William Hunter Vinoda Sharma Chetan Varma Derek Connolly |
author_sort |
George William Hunter |
title |
The EXCEL Trial: The Interventionalists’ Perspective |
title_short |
The EXCEL Trial: The Interventionalists’ Perspective |
title_full |
The EXCEL Trial: The Interventionalists’ Perspective |
title_fullStr |
The EXCEL Trial: The Interventionalists’ Perspective |
title_full_unstemmed |
The EXCEL Trial: The Interventionalists’ Perspective |
title_sort |
excel trial: the interventionalists’ perspective |
publisher |
Radcliffe Medical Media |
publishDate |
2021 |
url |
https://doaj.org/article/a1a821c0da314a6389592702409044bd |
work_keys_str_mv |
AT georgewilliamhunter theexceltrialtheinterventionalistsperspective AT vinodasharma theexceltrialtheinterventionalistsperspective AT chetanvarma theexceltrialtheinterventionalistsperspective AT derekconnolly theexceltrialtheinterventionalistsperspective AT georgewilliamhunter exceltrialtheinterventionalistsperspective AT vinodasharma exceltrialtheinterventionalistsperspective AT chetanvarma exceltrialtheinterventionalistsperspective AT derekconnolly exceltrialtheinterventionalistsperspective |
_version_ |
1718372752157573120 |